(Q45959519)

18 December 2017

title

Changes in serum tryptophan catabolism as an indicator of disease activity in adult T-cell leukemia/lymphoma. (English)

1 reference

18 December 2017

author name string

Masato Hoshi

1

1 reference

18 December 2017

Hiroyasu Ito

2

1 reference

18 December 2017

Hidetsugu Fujigaki

3

1 reference

18 December 2017

Masao Takemura

4

1 reference

18 December 2017

Takeshi Takahashi

5

1 reference

18 December 2017

Eiichi Tomita

6

1 reference

18 December 2017

Masami Ohyama

7

1 reference

18 December 2017

Ryo Tanaka

8

1 reference

18 December 2017

Hirofumi Ohtaki

9

1 reference

18 December 2017

Kuniaki Saito

10

1 reference

18 December 2017

Mitsuru Seishima

11

1 reference

18 December 2017

publication date

1 August 2009

1 reference

18 December 2017

published in

Leukemia & Lymphoma

1 reference

18 December 2017

volume

50

1 reference

18 December 2017

issue

8

1 reference

18 December 2017

page(s)

1372-1374

1 reference

18 December 2017

T-cell lines established from human T-lymphocytic neoplasias by direct response to T-cell growth factor

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10428190903045393

Human T cell leukemia virus type I (HTLV-I) and human diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190903045393

Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190903045393

Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190903045393

Serum tryptophan decrease correlates with immune activation and impaired quality of life in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190903045393

Indoleamine 2,3-dioxygenase is highly expressed in human adult T-cell leukemia/lymphoma and chemotherapy changes tryptophan catabolism in serum and reduced activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190903045393

IDO-expressing regulatory dendritic cells in cancer and chronic infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190903045393

Tryptophan deprivation sensitizes activated T cells to apoptosis prior to cell division

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190903045393

Treatment of autoimmune neuroinflammation with a synthetic tryptophan metabolite

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190903045393

Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190903045393

Eosinophil granulocytes account for indoleamine 2,3-dioxygenase-mediated immune escape in human non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190903045393

Inhibition of indoleamine 2,3-dioxygenase in dendritic cells by stereoisomers of 1-methyl-tryptophan correlates with antitumor responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190903045393

10.1080/10428190903045393

21 January 2018

Identifiers

DOI

1 reference

18 December 2017

1 reference

18 December 2017